Companies: 10,795·Total market cap: $144.5T
ProKidney Corp.

ProKidney Corp.

PROKNASDAQHealthcare● Active
$1.75
+$0.04(+2.50%)
Market Cap$259706532
P/E Ratio—
52W High$7.13
52W Low$0.54
Overview

ProKidney Corp. (PROK) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001850270 · PROK · NASDAQ · as of Jun 10, 2026

Filing snapshot

387
Total Filings
4
Latest Form
2026-05-29
Most Recent
2021
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001850270 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-18
Fiscal Year End
Mar 18, 2026
Accession No.
0001193125-26-113881
Primary Document
prok-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001850270 · Accession 0001193125-26-113881

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-15
View 10-Q on SEC
8-KCurrent Report
8-K
2026-05-29Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
8-K
2026-05-29
View
8-KCurrent Report
8-K
2026-05-15
View
10-QQuarterly Report
10-Q
2026-05-15
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-04-30
View
ARSARS
ARS
2026-04-17
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-17
View
DEF 14AProxy Statement
DEF 14A
2026-04-17
View
S-8Employee Stock Plan Registration
S-8
2026-03-18
View
8-KCurrent Report
8-K
2026-03-18
View
10-KAnnual Report
10-K
2026-03-18
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-02-12
View
8-KCurrent Report
8-K
2026-02-02
View
8-KCurrent Report
8-K
2026-01-12
View
EFFECTEFFECT
EFFECT
2025-11-18
View
8-KCurrent Report
8-K
2025-11-10
View
Showing 1–15 of 257 filingsForm 4 / 144 hidden· 387 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001850270  |  Exchange: NASDAQ · Healthcare

ProKidney Corp. (NASDAQ: PROK) has submitted 387 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2021. As a Healthcare sector company with CIK 0001850270, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is ProKidney Corp.'s most comprehensive regulatory disclosure. The most recent ProKidney Corp. 10-K was filed on 2026-03-18 for fiscal year ending 2026. Historical PROK 10-K annual reports are available from 2021 through 2026.

Investors researching ProKidney Corp. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-10
Related Companies SEC Filings — Healthcare
TNGX SEC Filings →NBTX SEC Filings →TYRA SEC Filings →SEPN SEC Filings →BCAX SEC Filings →SVRA SEC Filings →EYPT SEC Filings →KURA SEC Filings →
→ PROK Financials→ PROK Earnings→ PROK Insider Trades

Frequently Asked Questions

PROK SEC Filings · 8 questions

ProKidney Corp. (PROK) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 387 filings and access original documents at no cost. ProKidney Corp.'s CIK is 0001850270.

PROK SEC filingsProKidney Corp. SEC documentsfind PROK 10-K